Author

T. Jie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

L. Camacho· 2 shared R. L. Heimark· 2 shared A. Cardenas· 1 shared A. D. Grant· 1 shared B. A. Rheinheimer· 1 shared B. Rheinheimer· 1 shared E. S. Ong· 1 shared M. Padi· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Camacho

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell intrinsic signaling in MEN1 mutant pancreatic neuroendocrine tumors unveils novel signaling pathways associated with de-differentiation

B. A. Rheinheimer, R. L. Heimark, A. D. Grant, L. Camacho, M. Padi, T. Jie

The paper identifies MEN1 and FGFR3 mutations in pancreatic neuroendocrine tumors and links them to de-differentiation and aggressiveness, suggesting FGFR3 as a therapeutic target.

bioRxiv · Sep 29, 2020 · PreprintCancer Biology

Inhibition of Sphingosine-1-Phosphate signaling in pancreatic ductal adenocarcinoma leads to downregulation of growth and invasion

B. Rheinheimer, A. Cardenas, L. Camacho, E. S. Ong, T. Jie, R. L. Heimark

This study investigates the role of S1P signaling in pancreatic ductal adenocarcinoma, showing that its inhibition reduces growth and invasion.

bioRxiv · Sep 29, 2020 · PreprintCancer Biology